http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-202190921-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-593
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-741
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-375
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
filingDate 2019-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-202190921-A1
titleOfInvention SILICIC ACIDS FOR USE IN THE TREATMENT OF PERIODONTITIS
abstract Oral administration of bioavailable silicic acid, such as choline-stabilized silicic acid, for a period of at least 3 months daily, results in the prevention, inhibition and / or treatment of periodontitis and peri-implantitis. The treatment is particularly suitable in combination with appropriate cleaning of the teeth and disinfection of the oral cavity with one or more antiseptic and / or antimicrobial agents, administered at least once, and expediently regularly, for example once a year, twice a year, four times a day. a year or even every two months or every month. The treatment can be further enhanced by the simultaneous intake of vitamins, trace elements, as well as the introduction of a probiotic. Such additional agents can be used alone, but it is preferable that they be included in the bioavailable silicic acid.
priorityDate 2018-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525628

Total number of triples: 36.